From: Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?
TNFi | Model | Model content | AUC-ROC | Sens. | Spec. |
---|---|---|---|---|---|
ADA | Clinical | SJC, GC use, DAS28 | 0.75 | 80 % | 70 % |
Clinical + miRNAs | SJC, GC use, DAS28, miR-99a, miR-143 | 0.97 | 92 % | 91 % | |
ETN | Clinical | CRP | 0.68 | 67 % | 75 % |
Clinical + miRNAs | CRP, miR-197, miR-23a | 0.78 | 80 % | 79 % |